Korea based Medical Industry pioneer
Genoss Co Ltd
Genoss Co Ltd is Korea based Medical Industry pioneer. Since its establishment in 2004, GENOSS has put enormous efforts to become the world’s leading medical device company. Genoss is dedicated to creating exceptional medical devices through continued research and development. The primary mission set forth by GENOSS is to focus on delivering treatment solutions and promoting the well-being of its consumers and patients.
South Korean Medical device company
About GENOSS
Founded in South Korea in 2004, Genoss is a forward-thinking company with a bold vision – to become the best medical device manufacturer in the world. To make that possible, it strives to excel in every imaginable way. Firstly, it invests a considerable part of its global profits into research and development. This has allowed it to design some of the most impressive and innovative production technologies in the sphere of aesthetic medicine. Its advanced skin fillers Monalisa are made through a special HyBRID Technology. Thanks to it, the non-animal Hyaluronic Acid gel in these revolutionary anti-aging products has a structure that is stable, uniform and firm. This matters because patients who have undergone a non-surgical anti-wrinkle treatment with these superb filler injections will witness instant results that last for at least 6 months.
Exclusive Monalisa Distributor
About RIESSA
Riessa, was born at the junction of empowering individuals to embrace their timeless beauty. Riessa's essence is rooted in the philosophy that true beauty transcends age, and with our Monalisa dermal fillers, we aim to enhance and revitalize natural beauty at any stage of life. We the ONLY AUTHORIZED DISTRIBUTOR for MONALISA Dermal Fillers in INDIA.
Genoss & Riessa enterprise
Strengthening Innovation: Riessa Enterprise's Dynamic Partnership with Genoss
At Riessa, our journey has always been guided by a simple yet profound philosophy: to revolutionize the industry and empower individuals to feel confident and beautiful. We take a monumental step forward by joining forces with Genoss, a dynamic and forward-thinking entity that has been making waves in its own right. Genoss's commitment to advancing healthcare, biotechnology industry they specialize in, aligns perfectly with our ethos at Riessa. Together, our collaboration will amplify our capabilities and accelerate our impact on the lives of millions.
Monalisa Aesthetic Fillers
Dedication to Driving Innovation
GENOSS strives to prepare for a big leap forward into the endless competition of the world’s biotechnology market through its technical innovation. With a considerable portion of sales being spent on Research & Development and supported by a group of immensely experienced and talented R&D professionals, GENOSS has demonstrated a strong commitment to R&D and to manufacture products with world-beating quality.
In addition, GENOSS strictly fulfills and complies with the international quality regulations, including KGMP, ISO 13485 and ISO 9001. Furthermore, the CE mark and the FDA approval on each product confirm its conformity with all the legal requirements.
Genoss's Monalisa products
Quality above all
Genoss’ Monalisa product range can remove nearly all kinds of aging signs as they can be applied under the skin via injection to correct shallow lines, medium wrinkles and deep folds. Just like its state-of-the-art medical devices and products that vary from dental laboratory systems and vascular solutions to sophisticated spinal devices, its lines of HA-based anti-aging fillers are manufactured in strict compliance with CE, KFDA, and FDA standards. Therefore, patients and qualified plastic surgeons from around the globe do not need to worry about harsh side effects, second-tier quality, etc. This Korean medical company thoroughly tests and examines its products before putting them on the market and it is known for working in full accordance with GSQC or Global Standard Quality Control.
Monalisa Aesthetic Fillers
Trademark Ergonomic Design
Aside from developing and manufacturing high-class soft-tissue fillers, Genoss Co., Ltd. is also making the needles and single-use syringes for them. They have a trademark ergonomic design that helps medical practitioners to deliver patients with natural-looking results.
The presence of lidocaine in the formula of its entire Monalisa line of optimized skin fillers and the patented thin-wall needle that comes in the box with them means minimal pain and discomfort during treatment. Finally, the improved and purified Hyaluronic Acid composition of its effective dermal filler injections is why these products are so durable, easy to inject and easy to control. Genoss is the boss of professional-grade skin rejuvenation products based on non-animal HA.
Genoss's Global Network
Distributed in 40 countries
Europe and CIS : Germany, Italy, Russia, Spain, Switzerland, Slovakia, Hungary, Croatia, Lithuania, Ukraine, Albania
The Americas : United States, Mexico, Argentina, Colombia, Peru, Ecuador, Dominican Republic, Guatemala, Venezuela, Paraguay
Asia : China, Japan, India, Indonesia, Taiwan, Thailand, Vietnam, Malaysia, Bangladesh, Hong Kong, Pakistan, Mongolia
The Middle East / Africa : Saudi Arabia, United Arab Emirates, Egypt, Iraq, Kuwait, Morocco, Tunisia
Industry Pioneer
Genoss's Promise
Genoss takes special care to invest in future growth by using more than 20% of its annual revenue every year toward R&D, and building a team of outstanding researchers and experts from Korea and around the world. With uncompromising quality and continued innovation, it is Genoss's vision to become a global leader in medical device manufacturing that focuses on improved patient outcomes and satisfaction.
Having started with just the domestic approval of OSTEON bone graft in 2004, Genoss has since demonstrated tremendous growth as a medical device manufacturer with its now extensive product portfolio covering several specialties, such as facial plastics, ENT, dentistry, and orthopaedics. This is just the start of genoss's story; It is genoss's promise to continue addressing the current and evolving needs of the patient and doctor.
Sculpting perfection
Monalisa filler treatment area
Experience the transformative power of Monalisa, our cutting-edge soft tissue filler designed to reduce the appearance of fine lines, deep wrinkles, and volume loss. With its pure, cross-linked hyaluronic acid formulation containing 24mg/ml, Monalisa retains excellent volume effects for an extended period.
